CNBC February 13, 2025
Annika Kim Constantino

Key Points

– CVS Health could be starting to turn itself around after a dismal 2024.

– Its shares are up more than 45% this year, outperforming pharmacy rival Walgreens and other insurers like UnitedHealth Group and Cigna.

– The company’s stock plummeted last year, largely due to higher-than-expected medical costs in its insurance unit that hurt its bottom line, but some analysts are more optimistic about the company’s ability to navigate that challenge moving forward.

After a dismal 2024, CVS Health could be starting to turn itself around.

Some investors seem convinced, especially after the retail drugstore chain on Wednesday posted a big beat on fourth-quarter earnings and a 2025 profit outlook that was in line with expectations....

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Provider
OHSU hospital operating at 100%-plus capacity
Stanford Medicine Children’s Health maintains focus on equity in care
The Rise of Hospice Nurses as Authors, Social Media Influencers
MedPAC estimates $84B in Medicare Advantage overpayments in 2025: 10 notes
Big challenges for health system IT execs in the next 12 months

Share This Article